MedTrace Logo

Artemether-Lumefantrine Effectiveness in Guinea-Bissau 2

NCT01133314 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2021-05-26

No results posted yet for this study

Summary

The routine treatment of children with antimalarials will be monitored. Children with a positive malaria film and/or a positive rapid diagnostic test (RDT) will have a capillary blood sample taken to verify the diagnosis and to monitor the pattern of resistance.

Conditions

Sponsors & Collaborators

  • Bandim Health Project

    lead OTHER

Principal Investigators

  • Poul-Erik Kofoed, MD, Ph.d. · Bandim Health Project

Eligibility

Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-12-31
Completion
2016-07-31

Countries

  • Guinea-Bissau

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01133314 on ClinicalTrials.gov